Another mechanism of TMZ resistance in GBM patients is represented by unmethylated MGMT promoter tumours (Xu-Welliver and Pegg, 2002), where the enzyme proficiently repairs the chemotherapy-induced DNA damage. Here, MGMT is linked to neoplasm.